v3.26.1
Fair Value Measurements (Tables)
 12 Months Ended
Dec. 31, 2025
EBP 001  
EBP, Investment, Fair Value and NAV [Line Items]  
EBP, Investment, Fair Value and NAV
The following fair value hierarchy tables present information about each major class/category of the Plan’s investments measured at fair value:
 
Fair value measurements at December 31, 2025, using
 Quoted prices in active markets for identical assets
(Level 1)		Significant
other observable
inputs
(Level 2)		Significant
unobservable
inputs
(Level 3)		Total
Amgen stock$417,689,989 $— $— $417,689,989 
Cash and cash equivalents5,471,574 — — 5,471,574 
Collective trust funds— 6,275,138,481 — 6,275,138,481 
Common and preferred stocks92,034,453 — — 92,034,453 
Debt securities— 2,685 — 2,685 
Mutual funds255,411,543 — — 255,411,543 
Self-directed brokerage accounts1,117,018,349 2,742,408 — 1,119,760,757 
Total investments at fair value$1,887,625,908 $6,277,883,574 $— $8,165,509,482 
 
Fair value measurements at December 31, 2024, using
 Quoted prices in active markets for identical assets
(Level 1)		Significant
other observable
inputs
(Level 2)		Significant
unobservable
inputs
(Level 3)		Total
Amgen stock$344,055,715 $— $— $344,055,715 
Cash and cash equivalents3,466,558 — — 3,466,558 
Collective trust funds— 5,003,198,779 — 5,003,198,779 
Common and preferred stocks533,256,711 — — 533,256,711 
Debt securities— 2,979 — 2,979 
Mutual funds148,845,846 — — 148,845,846 
Self-directed brokerage accounts996,397,298 3,319,375 — 999,716,673 
Total investments at fair value$2,026,022,128 $5,006,521,133 $— $7,032,543,261